Diabetes Metab J.  2011 Apr;35(2):188-189. 10.4093/dmj.2011.35.2.188.

Letter: Basal C-peptide Level as a Surrogate Marker of Subclinical Atherosclerosis in Type 2 Diabetes Patients (Diabetes Metab J 2011;35:41-9)

• Lee MS
• Kim HJ

• KMID: 2281718
• DOI: http://doi.org/10.4093/dmj.2011.35.2.188

Abstract

No abstract available.

MeSH Terms

Atherosclerosis
Biomarkers
C-Peptide
Humans
C-Peptide

Reference

1. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998. 339:229–234.

2. Kim HJ, Ahn CW, Kang ES, Myoung SM, Cha BS, Won YJ, Lim SK, Kim KR, Huh KB, Lee HC. The level of 2-h post-challenge glucose is an independent risk factor of carotid intima-media thickness progression in Korean type 2 diabetic patients. J Diabetes Complications. 2007. 21:7–12.

3. Ridker PM, Brown NJ, Vaughan DE, Harrison DG, Mehta JL. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation. 2004. 109(25):Suppl 1. IV6–IV19.

4. Kim ST, Kim BJ, Lim DM, Song IG, Jung JH, Lee KW, Park KY, Cho YZ, Lee DH, Koh GP. Basal C-peptide level as a surrogate marker of subclinical atherosclerosis in type 2 diabetic patients. Diabetes Metab J. 2011. 35:41–49.

5. Bokemark L, Wikstrand J, Wedel H, Fagerberg B. Atherosclerosis and Insulin Resistance sstudy (AIR). Insulin, insulin propeptides and intima-media thickness in the carotid artery in 58-year-old clinically healthy men. The Atherosclerosis and Insulin Resistance study (AIR). Diabet Med. 2002. 19:144–151.

6. Kim BY, Jung CH, Mok JO, Kang SK, Kim CH. Association between serum C-peptide levels and chronic microvascular complications in Korean type 2 diabetic patients. Acta Diabetol. Epub 2011 Jan 7. DOI: 10.1007/s00592-010-0249-6.

7. Elkeles RS, Diamond JR, El-Bahghouti N, Dhanjil S, Nicolaides A, Geroulakos G, Renton S, Anyaoku V, Richmond W, Mather H, Sharp P. Relative fasting hypoinsulinaemia and ultrasonically measured early arterial disease in type 2 diabetes. The SENDCAP Study Group, St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention Study. Diabet Med. 1996. 13:247–253.

8. Selvin E, Coresh J, Golden SH, Boland LL, Brancati FL, Steffes MW. Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the atherosclerosis risk in communities study. Diabetes Care. 2005. 28:1965–1973.